16.81
price down icon2.55%   -0.44
after-market Dopo l'orario di chiusura: 16.81
loading
Precedente Chiudi:
$17.25
Aprire:
$17.26
Volume 24 ore:
1.18M
Relative Volume:
0.93
Capitalizzazione di mercato:
$1.55B
Reddito:
$2.98B
Utile/perdita netta:
$-300.00M
Rapporto P/E:
-4.9441
EPS:
-3.4
Flusso di cassa netto:
$225.00M
1 W Prestazione:
-3.39%
1M Prestazione:
+31.84%
6M Prestazione:
+225.15%
1 anno Prestazione:
-9.87%
Intervallo 1D:
Value
$16.20
$17.27
Intervallo di 1 settimana:
Value
$16.20
$17.69
Portata 52W:
Value
$3.97
$20.26

Fortrea Holdings Inc Stock (FTRE) Company Profile

Name
Nome
Fortrea Holdings Inc
Name
Telefono
877-495-0816
Name
Indirizzo
8 MOORE DRIVE, DURHAM
Name
Dipendente
14,500
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
FTRE's Discussions on Twitter

Confronta FTRE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
FTRE
Fortrea Holdings Inc
16.81 1.59B 2.98B -300.00M 225.00M -3.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.13 115.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
776.31 81.12B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
400.17 52.54B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
839.99 51.78B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
177.12 37.12B 447.02M -1.18B -906.14M -6.1812

Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-12-15 Aggiornamento Barclays Underweight → Equal Weight
2025-12-11 Aggiornamento Citigroup Neutral → Buy
2025-08-04 Aggiornamento Robert W. Baird Neutral → Outperform
2025-05-02 Iniziato Truist Hold
2025-04-10 Downgrade Barclays Equal Weight → Underweight
2024-12-11 Downgrade Citigroup Buy → Neutral
2024-12-06 Downgrade Robert W. Baird Outperform → Neutral
2024-09-25 Downgrade Jefferies Buy → Hold
2024-08-08 Downgrade Evercore ISI Outperform → In-line
2024-07-24 Ripresa Barclays Equal Weight
2024-06-06 Iniziato Goldman Neutral
2024-05-29 Iniziato TD Cowen Hold
2024-05-28 Iniziato Mizuho Neutral
2024-03-22 Iniziato Robert W. Baird Neutral
2024-03-06 Iniziato Deutsche Bank Hold
2024-01-05 Iniziato William Blair Mkt Perform
2024-01-04 Iniziato Jefferies Buy
2023-12-11 Aggiornamento Citigroup Neutral → Buy
2023-12-01 Aggiornamento Evercore ISI In-line → Outperform
2023-11-14 Aggiornamento Barclays Equal Weight → Overweight
2023-10-19 Iniziato Citigroup Neutral
2023-09-14 Iniziato Evercore ISI In-line
2023-08-16 Iniziato Barclays Equal Weight
2023-08-07 Iniziato BofA Securities Underperform
Mostra tutto

Fortrea Holdings Inc Borsa (FTRE) Ultime notizie

pulisher
Jan 02, 2026

Fortrea holdings COO Mark Morais sells $6,220 in stock - MSN

Jan 02, 2026
pulisher
Jan 02, 2026

Fortrea (NASDAQ:FTRE) Shares Down 5.6%Should You Sell? - MarketBeat

Jan 02, 2026
pulisher
Dec 30, 2025

Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Dec 30, 2025
pulisher
Dec 28, 2025

Fortrea Holdings Inc. $FTRE Shares Sold by Voya Investment Management LLC - MarketBeat

Dec 28, 2025
pulisher
Dec 27, 2025

Retail Trends: Why Fortrea Holdings Inc. stock is trending among retail tradersMarket Sentiment Report & Smart Investment Allocation Insights - moha.gov.vn

Dec 27, 2025
pulisher
Dec 25, 2025

Squarepoint Ops LLC Decreases Stake in Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 25, 2025
pulisher
Dec 24, 2025

Behavioral Patterns of FTRE and Institutional Flows - Stock Traders Daily

Dec 24, 2025
pulisher
Dec 24, 2025

What drives Fortrea Holdings Inc K67 stock priceMarket Entry Points & Exceptional Return Growth - earlytimes.in

Dec 24, 2025
pulisher
Dec 24, 2025

Assenagon Asset Management S.A. Lowers Stock Position in Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Viridian Therapeutics (VRDN), Fortrea Holdings Inc. (FTRE) and Cytokinetics (CYTK) - The Globe and Mail

Dec 24, 2025
pulisher
Dec 23, 2025

Fortrea Holdings (FTRE) price target increased by 18.02% to 13.36 - MSN

Dec 23, 2025
pulisher
Dec 21, 2025

Can Fortrea Holdings Inc. stock maintain growth trajectoryWeekly Profit Recap & Daily Price Action Insights - Улправда

Dec 21, 2025
pulisher
Dec 21, 2025

Why Fortrea Holdings Inc. stock remains on buy listsJuly 2025 Volume & Weekly High Return Stock Forecasts - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Will Fortrea Holdings Inc. stock see PE expansionProduct Launch & AI Based Buy and Sell Signals - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Why Fortrea Holdings Inc. (K67) stock appeals to dividend investorsWeekly Trading Summary & Daily Volume Surge Signals - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Why Fortrea Holdings Inc. stock is trending among retail tradersQuarterly Market Summary & Proven Capital Preservation Tips - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Death Cross: Can Fortrea Holdings Inc. stock maintain growth trajectoryJuly 2025 Weekly Recap & Daily Momentum Trading Reports - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Layoff Watch: Can Fortrea Holdings Inc. stock continue upward trendJuly 2025 Movers & AI Powered Trade Plan Recommendations - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Fortrea (FTRE) Stock Up 8% After Mizuho Raises Price TargetNews and Statistics - IndexBox

Dec 19, 2025
pulisher
Dec 19, 2025

Why Fortrea (FTRE) Stock Is Up Today - Finviz

Dec 19, 2025
pulisher
Dec 19, 2025

Is Fortrea Holdings Inc. stock a safe haven assetQuarterly Portfolio Report & Verified Entry Point Signals - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Fortrea (FTRE): Reassessing Valuation After a Sharp 3-Month Share Price Rebound - Yahoo Finance

Dec 19, 2025
pulisher
Dec 19, 2025

Smart Money: Why Fortrea Holdings Inc. stock is in analyst buy zoneForecast Cut & Community Shared Stock Ideas - ulpravda.ru

Dec 19, 2025
pulisher
Dec 19, 2025

Published on: 2025-12-19 16:51:02 - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Can Fortrea Holdings Inc. stock continue upward trendGlobal Markets & Real-Time Stock Price Movement Reports - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Why retail investors favor Fortrea Holdings Inc. stockWeekly Trade Report & Smart Investment Allocation Insights - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Why Fortrea Holdings Inc. stock is in analyst buy zoneWeekly Trade Analysis & Consistent Return Investment Signals - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Jana Partners adds Markel Group, exits Fortrea - MSN

Dec 18, 2025
pulisher
Dec 18, 2025

Will Fortrea Holdings Inc. stock deliver better than expected guidance - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Shareholders to Reach Out - ACCESS Newswire

Dec 18, 2025
pulisher
Dec 18, 2025

Fortrea (FTRE) Stock Update: Analyst Price Target Increase to $13.00News and Statistics - IndexBox

Dec 18, 2025
pulisher
Dec 18, 2025

Why Fortrea (FTRE) Stock Is Trading Up Today - Finviz

Dec 18, 2025
pulisher
Dec 18, 2025

Fortrea (NASDAQ:FTRE) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat

Dec 18, 2025
pulisher
Dec 17, 2025

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Fortrea Holdings Inc. (FTRE) and Novan (NOVN) - The Globe and Mail

Dec 17, 2025
pulisher
Dec 16, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Dec 16, 2025
pulisher
Dec 16, 2025

Fortrea (FTRE) Partnership With SCTbio: Is the Rebound Justified by Its Current Valuation? - Sahm

Dec 16, 2025
pulisher
Dec 16, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire

Dec 16, 2025
pulisher
Dec 16, 2025

Fortrea (NASDAQ:FTRE) Stock Rating Upgraded by Barclays - MarketBeat

Dec 16, 2025
pulisher
Dec 15, 2025

Fortrea Holdings Shares Higher After Barclays Upgrade - marketscreener.com

Dec 15, 2025
pulisher
Dec 15, 2025

Barclays Upgrades Fortrea Holdings (FTRE) - Nasdaq

Dec 15, 2025
pulisher
Dec 15, 2025

FTRE: Barclays Upgrades Fortrea Holdings, Boosts Price Target by 50% | FTRE Stock News - GuruFocus

Dec 15, 2025
pulisher
Dec 15, 2025

Barclays Upgrades Fortrea to Equal Weight From Underweight, Adjusts PT to $15 From $10 - marketscreener.com

Dec 15, 2025
pulisher
Dec 15, 2025

Barclays upgrades Fortrea stock rating to Equalweight on biotech recovery By Investing.com - Investing.com UK

Dec 15, 2025
pulisher
Dec 14, 2025

Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Dec 14, 2025
pulisher
Dec 13, 2025

Liquidity Mapping Around (FTRE) Price Events - news.stocktradersdaily.com

Dec 13, 2025
pulisher
Dec 13, 2025

Beck Mack & Oliver LLC Sells 916,179 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. ... - Bakersfield.com

Dec 12, 2025
pulisher
Dec 12, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire Inc.

Dec 12, 2025
pulisher
Dec 12, 2025

Fortrea (NASDAQ:FTRE) Shares Gap UpHere's What Happened - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

1,029,700 Shares in Fortrea Holdings Inc. $FTRE Acquired by Bank of Nova Scotia - MarketBeat

Dec 12, 2025
pulisher
Dec 11, 2025

Does Fortrea (FTRE) Pairing With SCTbio And Citigroup’s Upgrade Reveal A Deeper Strategic Shift? - Sahm

Dec 11, 2025

Fortrea Holdings Inc Azioni (FTRE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$38.86
price up icon 0.57%
$31.82
price up icon 3.31%
$101.42
price up icon 2.68%
$96.69
price up icon 1.57%
biotechnology ONC
$311.02
price up icon 2.37%
$177.12
price up icon 1.77%
Capitalizzazione:     |  Volume (24 ore):